Acne is the most common skin disease in the Philippines, affecting over 17 million people, including teens. It can be painful, embarrassing, and impact self-esteem, relationships, and happiness. Over 50% of patients with facial acne also have chest, shoulder, and back acne. Proper treatment and early intervention can help overcome acne, as patients invest time and money in hygiene habits and treatment products.
It is important for patients to seek treatment from a board-certified dermatologist for safe and effective prescription options like the newest retinoid innovation – Trifarotene cream.
It is an innovative topical single-agent retinoid cream proven safe and effective for acne on the face, shoulders, and back. Trifarotene cream contains the retinoid molecule, which helps the skin replace its old skin cells at a faster speed, exfoliating away the old cells in the process and preventing new acne from forming. Trifarotene works by specifically targeting the retinoic acid receptor gamma (RAR-y), the most prevalent receptor in the skin, to reduce inflammation and target the important factors that cause acne.
Trifarotene is the first new retinoid molecule to receive FDA approval for treating acne in over 25 years. It offers both dermatologists and acne patients a safe and effective prescription acne medication for the face, back, chest, and shoulders. Galderma, a world leader in developing innovative and safe dermatologist-approved skincare solutions, now brings Trifarotene to the Philippines market. The same company gave the world well-loved brands like Cetaphil, Benzac, and Restylane, among many others. With the addition of Trifarotene to its portfolio, the company further cements its claim as one of the most innovative dermatologist-recommended skincare-focused companies in the world today.
Trifarotene will only be prescribed by duly licensed healthcare practitioners, primarily dermatologists, and is recommended for patients 12 years and older.
